Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow Reinvestment Rate
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow Reinvestment Rate of 0.13x as of March 2026, reinvesting TL24.08 Million (capex TL24.08 Million ) from operating cash flow of TL180.45 Million. See Meditera Tibbi Malzeme Sanayi ve Ticaret free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Meditera Tibbi Malzeme Sanayi ve Ticaret generate cash.
Annual Cash Flow Reinvestment Rate for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year capital reinvestment analysis for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. See MEDTR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | TL191.67 Million | TL435.35 Million | TL191.67 Million | ▼ -18.8% |
| 2024 | 0.54x | TL423.12 Million | TL780.69 Million | TL263.52 Million | ▲ +4.1% |
| 2023 | 0.52x | TL417.10 Million | TL801.02 Million | TL299.70 Million | ▼ -97.2% |
| 2022 | 18.59x | TL94.79 Million | TL5.10 Million | TL51.35 Million | ▲ +4366.2% |
| 2021 | 0.42x | TL15.25 Million | TL36.64 Million | TL8.92 Million | ▲ +46.0% |
| 2020 | 0.29x | TL20.89 Million | TL73.26 Million | TL20.85 Million | ▼ -54.1% |
| 2019 | 0.62x | TL12.42 Million | TL20.01 Million | TL0.00 | ▲ +101.7% |
| 2018 | 0.31x | TL22.55 Million | TL73.26 Million | TL0.00 | — |